Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,600 signal articles · 207 in last 24h · 117,164 total before filter · latest 37m ago
207last 24h
1666last 7d
265● bullish (7d)
153● bearish (7d)
205publishers
AllMacro314Earnings734M&A96Regulatory27Product12Analyst25
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results
InvestorsHub8d agobullish
AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results

AbCellera (NASDAQ:ABCL) shares jumped 22% on Monday after the biotechnology company announced positive topline results from a Phase 2 clinical trial evaluating ABCL635 as a potential treatment for moderate-to-severe vasomotor symptoms associated with menopause. The study achieved its primary efficacy endpoints, demonstrating statistically significant reductions in both the frequency and severity of moderate-to-severe vasomotor symptoms at week four following a single dose compared with placebo.

SpaceX Stock Jumps Again After Lock-Up Rally. When’s the Next Release, What to Expect.
Barrons.com8d agobullish
SpaceX Stock Jumps Again After Lock-Up Rally. When’s the Next Release, What to Expect.

SpaceX stock was jumping again in Monday’s premarket—on pace for its highest close for a month, after snapping a 4-week losing run on Friday with a 16% surge following the end of a lockup period for shares. The Elon Musk-led satellite and AI company’s shares were rising 4% to $138.57 as investors regained appetite for the stock after a torrid time since its closing high of $201.80 on June 16—reached two days after its IPO on June 12. Wall Street had widely braced for severe selling pressure on Thursday, when SpaceX’s first lockup expiration freed roughly 911 million restricted insider shares.

Investing.com8d agobullish
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout

Investing.com - U.S. stock index futures edged higher on Monday, while Dow futures were little changed, as investors scaled back hopes for a breakthrough in the Middle East and looked ahead to key inflation data due later this week for fresh clues on the Federal Reserve’s interest rate path.

The Energy Drink Buyout Prize Beverage Giants Are Circling
24/7 Wall St.8d agobullish
The Energy Drink Buyout Prize Beverage Giants Are Circling

Celsius Holdings shares have cratered nearly 40% this year, shrinking its market cap to a size beverage giants can actually swallow. With PepsiCo already holding equity and activist investors circling, the question is no longer if a deal happens but who makes the move first.

3 Market-Beating Stocks Worth Investigating
StockStory8d agobullish
3 Market-Beating Stocks Worth Investigating

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

3 Market-Beating Stocks for Long-Term Investors
StockStory8d agobullish
3 Market-Beating Stocks for Long-Term Investors

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.

Intel launches $15 billion share sale as turnaround rally lifts stock
Reuters8d agobullish
Intel launches $15 billion share sale as turnaround rally lifts stock

Intel is planning to raise $15 billion through a share ‌sale, the U.S. chipmaker said ‌on Monday as it looks to fund the ​costly build-out of its chip contract manufacturing business by cashing in on a stock surge fueled by its turnaround efforts. Once ‌the dominant ⁠force in the global chip industry, Intel is investing heavily in ⁠new facilities and advanced packaging capabilities as it seeks to challenge industry ​leader such ​as TSMC in ​contract chip manufacturing. Its ‌shares fell more than 3% in premarket trading, likely on concerns about shareholder dilution from the stock sale.

3 Beaten-Down Healthcare Stocks to Buy in August
24/7 Wall St.8d agobullish
3 Beaten-Down Healthcare Stocks to Buy in August

Healthcare just posted the best three-month run of any S&P 500 sector, yet two of the three biggest pharma names by market cap are still trailing the broader market. That gap between performance and fundamentals is creating a window that income and growth investors rarely see at the mega-cap level.

1 Profitable Stock on Our Buy List and 2 We Find Risky
StockStory8d agobullish
1 Profitable Stock on Our Buy List and 2 We Find Risky

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.